Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Galectin Therapeutic
(NQ:
GALT
)
5.120
USD
+0.240 (+4.92%)
Official Closing Price
/ Updated:
5:04 PM EDT, Oct 16, 2018
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
312,300
Open
4.880
Bid (Size)
4.200 (5)
Ask (Size)
6.000 (10)
Prev. Close
4.880
Today's Range
4.880 - 5.240
52wk Range
1.280 - 9.490
Shares Outstanding
37,740,647
Dividend Yield
N/A
Performance
YTD
+32.64%
+32.64%
1 Month
-10.80%
-10.80%
3 Month
-15.09%
-15.09%
6 Month
+47.98%
+47.98%
1 Year
+121.65%
+121.65%
Top News
More News
Galectin Therapeutics to Participate in The ROTH Capital Battle of the NASH Thrones Investment Conference
October 15, 2018
Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that management will participate in the upcoming ROTH Capital Battle of...
Read More
from
GlobeNewswire News Releases
Galectin Therapeutics to Present at The ROTH Capital Battle of the NASH Thrones Investment Conference
October 15, 2018
Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that management will participate in the upcoming ROTH Capital Battle of...
Read More
from
GlobeNewswire News Releases
More News
Read More
Market Trends Toward New Normal in Altra Industrial Motion, IDEXX Laboratories, BioTelemetry, Galectin Therapeutics, NETGEAR, and Merck & Co. — Emerging Consolidated Expectations, Analyst Ratings
October 11, 2018
from
GlobeNewswire News Releases
Galectin Therapeutics, Inc. Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA® in Advanced Melanoma and Expansion of the Trial
September 20, 2018
from
GlobeNewswire News Releases
Galectin Therapeutics to Present at H.C. Wainwright 20th Annual Global Investment Conference
August 28, 2018
from
GlobeNewswire News Releases
First Week of January 2021 Options Trading For Galectin Therapeutics (GALT)
September 18, 2018
category
Stocks
from
Market News Video
52 Biggest Movers From Friday
September 24, 2018
category
REV
,
LTS
,
HYRE
, and 64 more.
from
Benzinga
40 Stocks Moving In Friday's Mid-Day Session
September 21, 2018
category
GTXI
,
Movers & Shakers
,
CRSP
, and 49 more.
from
Benzinga
56 Biggest Movers From Yesterday
September 21, 2018
category
SUPV
,
GALT
,
Trading Ideas
, and 65 more.
from
Benzinga
28 Stocks Moving In Monday's Pre-Market Session
September 17, 2018
category
RUTH
,
News
,
LPL
, and 40 more.
from
Benzinga
The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs
September 16, 2018
category
TPIV
,
JNJ
,
ARGX
, and 32 more.
from
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
